Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can cooking classes cut heart risk? new study tests community approach

NCT ID NCT04305431

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 17, 2026 · Updated 10 times

Summary

This study explores whether a community-based cooking program can help African-American adults at risk for heart disease cook and eat healthier. About 43 participants from Washington, D.C. will take surveys, attend cooking classes led by a chef, and track their eating habits. The goal is to see if the program is practical and well-received, not to test a medical treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

43 people

The number who actually took part.

Started

Feb 2021

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

A government research agency

The lead sponsor is the US National Institutes of Health.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 99 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* FIRST PHASE: A sample of AA adults (n= 20) living in Wards 7 or 8 of Washington, D.C. will be recruited for this phase. INCLUSION CRITERIA: English-speaking Self-identified AA adults (defined as age greater than or equal to 18) Live in Wards 7 or 8 in Washington, D.C. At least one self-reported risk factor for CV disease known by participant or told to participant by a clinician within the last 12 months. Specific risk factors are: * overweight or obese (self-reported height and weight compute to BMI if needed greater than or equal to 25) * elevated waist to hip ratio * elevated cholesterol * clinical hypertension or prehypertension * prediabetes * elevated fasting glucose level on laboratory report * current smoker or prior (within the past 12 months) smoker. EXCLUSION CRITERIA: Under the age of 18 Do not live in Wards 7 or 8 in Washington, D.C. No risk factors for CVD Or adults not of AA descent (self-identified) Non-English speaking SECOND PHASE: A sample of AA adults (n= 35) living in Wards 7 or 8 of Washington, D.C. will be recruited for this phase. INCLUSION CRITERIA: English-speaking Self-identified AA adults (defined as age greater than or equal to 18) Who live in Wards 7 or 8 in Washington, D.C. At least one self-reported risk factor for CV disease known by participant or told to participant by a clinician within the last 12 months. Specific risk factors are: * overweight or obese (self-reported height and weight compute to BMI if needed \>= 25) * elevated waist to hip ratio * elevated cholesterol * clinical hypertension or prehypertension * prediabetes * elevated fasting glucose level on laboratory report * current smoker or prior (within the past 12 months) smoker. Not pregnant at the time of screening and enrollment.\* Willing to not attend or enroll in another cooking/culinary education program or class during participation in this study Not enrolled currently or in the prior 12 months (at time of recruitment) in another ongoing cooking/culinary education program or class EXCLUSION CRITERIA: AAs who are not age greater than or equal to 18 AA Adults not living in Wards 7 or 8 in Washington, D.C. AA Adults living in the same household as another participant AA adults without at least one risk factor for CVD Or adults not of AA descent Non-English speaking Those enrolled currently or in the prior 12 months at time of recruitment in another ongoing cooking/culinary education program Those not willing to not attend or enroll in another cooking/culinary education program or class during participation in this study \* If individuals become pregnant during their participation, they can continue to participate if they want to. The pregnant participant will not undergo DEXA scanning procedure.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cooking are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.